10x Genomics Analyst Ratings
BenzingaApr 18 08:12 ET
10x Genomics Analyst Ratings
BenzingaApr 10 15:37 ET
Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG) and LivaNova (LIVN)
TipRanksApr 10 02:51 ET
UBS Adjusts 10x Genomics Price Target to $52 From $44, Maintains Neutral Rating
MT NewswiresFeb 21 11:52 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Gilead Sciences (GILD), Travere Therapeutics (TVTX) and 10x Genomics (TXG)
TipRanksFeb 16 17:40 ET
10x Genomics Analyst Ratings
BenzingaFeb 16 09:47 ET
Stifel Nicolaus Sticks to Its Buy Rating for 10x Genomics (TXG)
TipRanksFeb 16 08:06 ET
Maintaining Buy Rating on 10x Genomics Amidst Strong Xenium Sales and Promising Future Product Launches
TipRanksFeb 16 07:20 ET
10x Genomics (TXG) Initiated With a Buy at Barclays
TipRanksFeb 16 06:58 ET
10x Genomics Poised for Growth: Buy Rating Affirmed Amid Strong Spatial Segment Performance and Solid Financial Outlook
TipRanksFeb 15 22:25 ET
10x Genomics Analyst Ratings
BenzingaJan 25 09:36 ET
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), 10x Genomics (TXG) and Altimmune (ALT)
TipRanksJan 22 14:10 ET
Analysts Offer Insights on Healthcare Companies: NeuroPace (NPCE), Alignment Healthcare (ALHC) and 10x Genomics (TXG)
TipRanksJan 9 05:11 ET
The Latest Analyst Ratings for 10x Genomics
BenzingaDec 14, 2023 10:00 ET
Guggenheim Initiates Coverage On 10x Genomics With Buy Rating, Announces Price Target of $60
BenzingaDec 14, 2023 05:59 ET
10x Genomics Analyst Ratings
BenzingaDec 13, 2023 12:00 ET
B of A Securities Upgrades 10x Genomics to Neutral, Raises Price Target to $54
BenzingaDec 12, 2023 07:27 ET
10x Genomics Analyst Ratings
BenzingaDec 12, 2023 07:26 ET
UBS Lowers 10x Genomics Price Target to $44 From $62, Maintains Neutral Rating
MT NewswiresNov 7, 2023 13:19 ET
Analysts Offer Insights on Technology Companies: DigitalOcean Holdings (DOCN), 10x Genomics (TXG) and Epam Systems (EPAM)
TipRanksNov 3, 2023 07:50 ET
No Data
No Data